• 2 years ago
Dementia neurologist Dr Liz Coulthard describes a news drug called Lecanemab as a "step change" in the treatment of Alzheimer's, after clinical trials showed it can slow the advance of the disease by a quarter. Report by Blairm. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Recommended